Breakthrough in cancer vaccine development expected in 2025, British scientists say

The year 2025 could mark a new era in the development of a cancer vaccine, signifying a major breakthrough in this field, according to British scientists.

Report informs citing the British magazine The Economist that the recent cancer vaccine trials have yielded successful results, with the latest samples demonstrating efficacy. Researchers are currently investigating the vaccine's effectiveness against skin, brain, and lung tumors.

There is hope that cancer vaccines will advance to the point where they reduce the need for more invasive treatments such as chemotherapy or surgery," the article states.

To create the vaccine, scientists require tumor samples. They then sequence the tumor's genome and search for all possible genetic mutations.